Multiple Sclerosis Trial, Not Yet Recruiting NCT07645937 Sponsor: Hanifi Bal Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07645937
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 65 years old
  • People who have been diagnosed with relapsing-remitting multiple sclerosis based on the revised McDonald criteria
  • People whose MS disability level falls within a specific range on a standard scale called the EDSS, with a score between 2.5 and 3.5 (confirm with trial site)
  • People whose MS has been clinically stable
  • People who have not had a relapse in the past 3 months
  • People who have not used corticosteroid medications in the past 3 months
  • People who are physically able to take part in an exercise training program
  • People who are willing and able to provide written informed consent

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a history of deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the lungs)
  • People with peripheral vascular disease, which affects blood flow to the limbs
  • People with high blood pressure that is not well controlled
  • People with severe heart disease
  • People who are pregnant
  • People who have recently had surgery or an injury to the lower limbs
  • People with muscle, bone, or neurological conditions that would interfere with participating in exercise
  • People who have medical reasons that make a technique called blood flow restriction training unsafe for them (confirm with trial site)
  • People who are already taking part in another structured exercise trial at the same time as this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: seçil özkurt, Dr., Istinye University

Phone: +905532139440

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Hanifi Bal
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 March 2027

Primary endpoints

Change in Rectus Femoris Muscle Thickness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov